Stock Events

Phreesia 

$20.16
16
+$0+0% Heute

Statistik

Tag Hoch
20.16
Tag Tief
20.15
52W Hoch
35
52W Niedrig
12.27
Volumen
1,091
Durch. Volumen
201
Marktkap.
-
KGV
-
Dividendenrendite
-
Dividende
-

Demnächst

Gewinne

4DecErwartet
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Weiter
-0.7
-0.56
-0.42
-0.28
Erwartetes EPS
-0.278777
Tatsächliches EPS
K.A.

Leute folgen auch

Diese Liste basiert auf den Watchlists von Personen auf Stock Events, die 0A23.LSE folgen. Es handelt sich nicht um eine Anlageempfehlung.

Wettbewerber

Diese Liste ist eine Analyse basierend auf aktuellen Marktereignissen. Es ist keine Anlageempfehlung.

Über

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Show more...
CEO
Mr. Chaim Indig
Mitarbeiter
1701
Land
United States
ISIN
US71944F1066

Börsen